1,3-dihydro-imidazo[4,5-C]quinolin-2-ones as lipid kinase inhibitors
US7994170B2 · kind B2 · utility
9Cited by
3References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 12, 2009 |
| Grant date | Aug 9, 2011 |
| Priority date | — |
| Expiry date | Oct 12, 2029 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to novel organic compounds of formula (I)processes for the preparation thereof, the application thereof in a process for the treatment of the human or animal body, the use thereof—alone or in combination with one or more other pharmaceutically active compounds—for the treatment of an inflammatory or obstructive airway disease, such as asthma, disorders commonly occurring in connection with transplantation, or a proliferative disease, such as a tumor disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.